Trial
NCT07216833
Decitabine and Nivolumab in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Case Comprehensive Cancer Center
Collaborators
—
Condition
Head and Neck Cancer
Intervention
Decitabine
Why stopped
PI leaving the institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-22